- Home
- BLFS
as 07-26-2024 4:00pm EST
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 1.0B | IPO Year: | 1989 |
| Target Price: | $24.33 | AVG Volume (30 days): | 330.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.42 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.92 - $24.15 | Next Earning Date: | 08-06-2024 |
| Revenue: | $137,296,000 | Revenue Growth: | -15.89% |
| Revenue Growth (this year): | -23.17% | Revenue Growth (next year): | 12.58% |
Stock Insider Trading Activity of BioLife Solutions Inc. (BLFS)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Jul 1 '24 | Sell | $21.03 | 3,000 | $63,090.00 | 61,683 | SEC Form 4 |
| Berard Todd | BLFS | Chief Marketing Officer | Jun 14 '24 | Sell | $20.18 | 10,000 | $201,800.00 | 108,894 | SEC Form 4 |
| Foster Karen A. | BLFS | Chief Quality and Operations | May 29 '24 | Sell | $21.78 | 408 | $8,886.24 | 158,171 | SEC Form 4 |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | May 29 '24 | Sell | $21.78 | 517 | $11,260.26 | 318,483 | SEC Form 4 |
| Wichterman Troy | BLFS | Chief Financial Officer | May 29 '24 | Sell | $21.78 | 574 | $12,501.72 | 125,969 | SEC Form 4 |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | May 29 '24 | Sell | $21.78 | 345 | $7,514.10 | 64,683 | SEC Form 4 |
| Berard Todd | BLFS | Chief Marketing Officer | May 29 '24 | Sell | $21.78 | 345 | $7,514.10 | 118,894 | SEC Form 4 |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | May 17 '24 | Sell | $22.18 | 57 | $1,264.26 | 65,028 | SEC Form 4 |
| Wichterman Troy | BLFS | Chief Financial Officer | May 17 '24 | Sell | $22.18 | 115 | $2,550.70 | 126,543 | SEC Form 4 |
| Berard Todd | BLFS | Chief Marketing Officer | May 17 '24 | Sell | $22.18 | 73 | $1,619.14 | 119,239 | SEC Form 4 |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | May 17 '24 | Sell | $22.18 | 98 | $2,173.64 | 319,000 | SEC Form 4 |
| Foster Karen A. | BLFS | Chief Quality and Operations | May 17 '24 | Sell | $22.18 | 85 | $1,885.30 | 158,579 | SEC Form 4 |
| Berard Todd | BLFS | Chief Marketing Officer | May 15 '24 | Sell | $22.67 | 10,000 | $226,700.00 | 119,312 | SEC Form 4 |
| Foster Karen A. | BLFS | Chief Quality and Operations | Apr 18 '24 | Sell | $15.31 | 481 | $7,364.11 | 158,664 | SEC Form 4 |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Apr 18 '24 | Sell | $15.31 | 348 | $5,327.88 | 65,495 | SEC Form 4 |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Apr 18 '24 | Sell | $16.50 | 410 | $6,765.00 | 65,085 | SEC Form 4 |
| Berard Todd | BLFS | Chief Marketing Officer | Apr 18 '24 | Sell | $15.31 | 332 | $5,082.92 | 129,312 | SEC Form 4 |
| Wichterman Troy | BLFS | Chief Financial Officer | Apr 18 '24 | Sell | $15.31 | 956 | $14,636.36 | 126,658 | SEC Form 4 |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Apr 18 '24 | Sell | $15.31 | 584 | $8,941.04 | 319,098 | SEC Form 4 |
| Berard Todd | BLFS | Chief Marketing Officer | Apr 15 '24 | Sell | $15.67 | 10,000 | $156,700.00 | 129,644 | SEC Form 4 |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Apr 1 '24 | Sell | $17.65 | 4,000 | $70,600.00 | 65,843 | SEC Form 4 |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Mar 27 '24 | Sell | $17.99 | 454 | $8,167.46 | 319,682 | SEC Form 4 |
| Foster Karen A. | BLFS | Chief Quality and Operations | Mar 27 '24 | Sell | $17.99 | 395 | $7,106.05 | 159,145 | SEC Form 4 |
| Berard Todd | BLFS | Chief Marketing Officer | Mar 27 '24 | Sell | $17.99 | 515 | $9,264.85 | 139,644 | SEC Form 4 |
| Wichterman Troy | BLFS | Chief Financial Officer | Mar 21 '24 | Sell | $17.83 | 520 | $9,271.60 | 127,614 | SEC Form 4 |
Latest BioLife Solutions Inc. News
BLFS Breaking Stock News: Dive into BLFS Ticker-Specific Updates for Smart Investing
Simply Wall St.
11 hours ago
Is It Time To Consider Buying BioLife Solutions, Inc. (NASDAQ:BLFS)?
PR Newswire
a day ago
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024
Argus Research
3 days ago
BLFS: What does Argus have to say about BLFS?
Argus Research
10 days ago
BLFS: Raising target price to $24.00
Zacks
14 days ago
What Makes BioLife Solutions (BLFS) a Good Fit for 'Trend Investing'
Argus Research
17 days ago
BLFS: Lowering target price to $20.00
Simply Wall St.
a month ago
A Look At The Intrinsic Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)
GuruFocus.com
a month ago
Insider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS)
Compare BLFS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BLFS BioLife Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.